EXPRESSION OF WILD-TYPE AND MUTANT P53 PROTEINS BY RECOMBINANT VACCINIA VIRUSES

被引:17
作者
RONEN, D
TEITZ, Y
GOLDFINGER, N
ROTTER, V
机构
[1] TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN MICROBIOL,IL-69978 TEL AVIV,ISRAEL
[2] WEIZMANN INST SCI,DEPT CELL BIOL,IL-76100 REHOVOT,ISRAEL
关键词
D O I
10.1093/nar/20.13.3435
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To facilitate the purification of wild type p53 protein, we established a recombinant p53 vaccinia viral expression system. Using this efficient eukaryotic expression vector, we found that the expressed p53 proteins retained their specific structural characteristics. A comparison between wild type and mutant p53 proteins showed the conservation of the typical subcellular localization and the expression of specific antigenic determinants. Furthermore, wild type p53 exhibited a typical binding with large T antigen, whereas no binding was detected with mutant p53. Both wild type and mutant p53 proteins were highly stable and constituted 5 - 7% of total protein expressed in the infected cells. These expression recombinant viruses offer a simple, valuable system for the purification of wild type and mutant p53 proteins that are expressed abundantly in eukaryotic cells.
引用
收藏
页码:3435 / 3441
页数:7
相关论文
共 65 条
[11]  
DEPPERT W, 1990, ONCOGENE, V5, P1701
[12]   P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS [J].
DILLER, L ;
KASSEL, J ;
NELSON, CE ;
GRYKA, MA ;
LITWAK, G ;
GEBHARDT, M ;
BRESSAC, B ;
OZTURK, M ;
BAKER, SJ ;
VOGELSTEIN, B ;
FRIEND, SH .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) :5772-5781
[13]  
EDUARDS RH, 1988, MOL CELL BIOL, V8, P2456
[14]   WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION [J].
ELIYAHU, D ;
MICHALOVITZ, D ;
ELIYAHU, S ;
PINHASIKIMHI, O ;
OREN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8763-8767
[15]  
ELIYAHU D, 1988, ONCOGENE, V3, P313
[16]   PRESENCE OF A POTENT TRANSCRIPTION ACTIVATING SEQUENCE IN THE P53 PROTEIN [J].
FIELDS, S ;
JANG, SK .
SCIENCE, 1990, 249 (4972) :1046-1049
[17]   ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE [J].
FINLAY, CA ;
HINDS, PW ;
TAN, TH ;
ELIYAHU, D ;
OREN, M ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :531-539
[18]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[19]   CHARACTERIZATION OF HUMAN IMMUNODEFICIENCY VIRUS GAG POL GENE-PRODUCTS EXPRESSED BY RECOMBINANT VACCINIA VIRUSES [J].
FLEXNER, C ;
BROYLES, SS ;
EARL, P ;
CHAKRABARTI, S ;
MOSS, B .
VIROLOGY, 1988, 166 (02) :339-349
[20]   P53 AND DNA POLYMERASE-ALPHA COMPETE FOR BINDING TO SV40 T-ANTIGEN [J].
GANNON, JV ;
LANE, DP .
NATURE, 1987, 329 (6138) :456-458